Apple is working on an artificial intelligence-based health coaching service and new emotion-tracking technology, its latest attempt to lock users…
Plans
![Banner Tucson Custom Weight Loss Program Diet, Exercise Plans [Beuzz] 2 Banner Tucson Custom Weight Loss Program Diet, Exercise Plans](https://beuzz.club/wp-content/uploads/2023/04/Banner-Tucson-Custom-Weight-Loss-Program-Diet-Exercise-Plans-Beuzz.jpg)
Banner Tucson Custom Weight Loss Program Diet, Exercise Plans [Beuzz]
Cindy Colbert lost her husband in March 2020, and a week later the world went dark. With businesses closed and…
![Can ChatGPT design safe and effective training plans for you? [Beuzz] 3 Person using tablet on a yoga mat](https://beuzz.club/wp-content/uploads/2023/04/1681514434_Can-ChatGPT-design-safe-and-effective-training-plans-for-you.jpg)
Can ChatGPT design safe and effective training plans for you? [Beuzz]
ChatGPT generates responses to word prompts with amazing (for the most part) speed and accuracy. With seemingly so much power,…
![Biden to expand migrants' access to health plans: US officials [Beuzz] 11 hulu](https://beuzz.club/wp-content/uploads/2023/04/Biden-to-expand-migrants-access-to-health-plans-US-officials.jpg)
Biden to expand migrants’ access to health plans: US officials [Beuzz]
WASHINGTON– President Joe Biden is set to announce that his administration is expanding eligibility for Medicaid and Affordable Care Act…
![Teva and Viatris win US appeal in Parkinson's disease drug patent fight; Novavax Cut Costs by $50 Million, Plans to Cut More, CEO Says, and More [Beuzz] 12 Teva and Viatris win US appeal in Parkinson's disease drug patent fight; Novavax Cut Costs by $50 Million, Plans to Cut More, CEO Says, and More](https://beuzz.club/wp-content/uploads/2023/04/Teva-and-Viatris-win-US-appeal-in-Parkinsons-disease-drug.jpeg)
Teva and Viatris win US appeal in Parkinson’s disease drug patent fight; Novavax Cut Costs by $50 Million, Plans to Cut More, CEO Says, and More [Beuzz]
Here is a summary of health news briefs. Teva and Viatris win US appeal in Parkinson’s disease drug patent fight…